But the WHO, NIH, and FDA all recommend that you avoid using it.
by Steve Kirsch
July 22, 2022
A new large prospective observational study of 88,000 people shows ivermectin works; the greater the dose, the better it works.
Regular use of ivermectin as prophylaxis for COVID-19 led up to 92% reduction in COVID-19 mortality rate in a dose-response manner: results of a prospective observational study of a strictly controlled population of 88,012 subjects among 223,128 participants
